FDC Ltd, Aurangabad-based pharma Company, has achieved impressive performance during the year ended March 2004 and its net profit has taken quantum jump of 66.5 per cent to Rs 66.27 crore from Rs 39.80 crore in the previous year. The net sales increased almost by 30 per cent to Rs 278.38 crore from Rs 214.24 crore. The board of directors recommended a final dividend of 50 per cent on the post bonus equity share capital in addition to the interim dividend of 125 per cent already declared and paid on pre bonus equity, making an annualized dividend of 225 per cent.
The company has already announced bonus shares in the ratio of 1:1 by capitalizing a sum of Rs 9.57 crore. The earning per share of face value of Rs 1, after considering the said bonus equity shares, worked out to Rs 3.46 as against Rs 2.07
The company's other income increased by 118 per cent during the year ended March 2004 to Rs 19.35 crore from Rs 8.86 crore in the previous year. This strong growth in other income and nil liability of interest assisted to push its bottomline. The profit before interest, depreciation, taxation and exceptional items moved up by 53.6 per cent to Rs 86 crore from Rs 56 crore in the previous year. The company provided Rs 1.42 crore for exceptional items in respect of amortization of VRS expenditure.
The company is exporting to more than 45 countries and is government recognised export house. The company has been concentrating on developing exports in regulated markets like UK and USA as against other markets in CIS or third world countries. Its Roha plant is approved by USFDA and also holding WHO-GMP certifications.